Neurodegeneration and dementia are common complications of AIDS caused by human immunode®ciency virus type 1 (HIV-1) infection of the central nervous system. HIV-1 target cells in the brain include microglia, in®ltrating macrophages and astrocytes, but rarely neurons. Astrocytes play an important role in the maintenance of the synaptic micro-environment and in neuronal signal transmission. To investigate potential changes in cellular gene expression associated with HIV-1 infection of astrocytes, we employed an ecient and sensitive rapid subtraction hybridization approach, RaSH. Primary human astrocytes were isolated from abortus brain tissue and low-passage cells were infected with HIV-1. To identify genes that display both early and late expression modi®cations after HIV-1 infection and to avoid cloning genes displaying normal cell cyclē uctuations in astrocytes, RNAs were isolated and pooled from 6, 12, 24 h and 3 and 7 day uninfected and infected cells and used for RaSH. Temporal cDNA libraries were prepared from double-stranded cDNAs that were enzymatically digested into small fragments, ligated to adapters, PCR ampli®ed, and hybridized by incubation of tester and driver PCR fragments. By subtracting temporal cDNAs derived from uninfected astrocytes from temporal cDNAs made from HIV-1 infected cells, genes displaying elevated expression in virus infected cells, termed astrocyte elevated genes (AEGs), were identi®ed. Both known and novel AEGs, not reported in current DNA databases, are described that display early or late expression kinetics following HIV-1 infection or treatment with recombinant HIV-1 envelope glycoprotein (gp120). For selected AEGs, expression of their protein products was also tested by Western blotting and found to display elevated expression following HIV-1 infection. The comparable pattern of regulation of the AEGs following HIV-1 infection or gp120 treatment suggest that HIV-1 exposure of astrocytes, even in the absence of productive infection, can induce changes in cellular gene expression.
Introduction
Glial cells are the predominant cell type in the brain, constituting more than 50% of the total cell count and outnumbering neurons 10-fold (Pope, 1978; Rutka et al., 1997) . Two major subtypes of glia are distinguished by their distinct functions in the nervous system: oligodendrocytes, which form myelin sheaths around nerve cell axons, and astrocytes, which maintain brain homeostasis and respond to pathogens and brain injury (Benveniste, 1992; Verkhratsky et al., 1998) . Historically, astrocytes were considered to provide mostly passive support to neurons and the overall function of the nervous system. Recent studies question this hypothesis and suggest that astrocytes also play a critical role in several aspects of signal transmission and that defects in these functions may lead to neurodegeneration (Anderson and Swanson, 2000; Choi, 1988; Rothstein et al., 1996; Verkhratsky et al., 1998) . For example, the high-anity excitatory amino acid transport systems acting through astrocyte-speci®c transporters EAAT1 and EAAT2 are thought to be primarily responsible for maintenance of low levels of free intrasynaptic L-glutamate, the major neurotransmitter in the brain (Anderson and Swanson, 2000; Benveniste, 1992; Choi, 1988) . Defects that speci®cally abrogate this function result in accumulation of extracellular glutamate in synaptic clefts and overexcitation and death of neurons in the process of glutamate excitotoxicity (Choi, 1988 ; Gegelashvili and Schousboe, 1997; Tanaka et al., 1997) . At least one neurodegenerative disease, Amyotropic Lateral Sclerosis, has been linked to a signi®cant decrease of highanity sodium-dependent glutamate transport in synaptic membranes (Rothstein et al., 1992) and a selective loss of the transporter EAAT2 . Similar defects are implicated in Alzheimer disease, stroke/ischemia, epilepsy, and HIV-1-associated dementia (HAD) (Choi, 1988; Kaul et al., 2001; Maragakis and Rothstein, 2001) . In addition to their role in glutamate removal from synapses, astrocytes signi®cantly increase the number of synapses and enhance synaptic ecacy by altering pre-and postsynaptic functions in vitro (Oliet et al., 2001; Ullian et al., 2001) . Finally, astrocytes appear to share many excitable properties with neurons, including expression of functional neuronal nicotinic acetylcholine receptors (nACHRs) and competence for Ca ++ -dependent glutamate release, thus permitting intercellular signaling between astrocytes and neurons and, possibly, modulation of neuronal signal transmission by astrocytes (Iino et al., 2001; Sharma and Vijayaraghavan, 2001; Ullian et al., 2001) . Overall, these studies suggest that astrocytes and neurons are functionally integrated and that pathogenic stimuli that adversely aect astrocytes will directly impact on neuronal function and survival.
Studies have focused on investigation of HIV-1 infection in neural cells and the potential contribution of such infections to neurodegeneration and HAD. The pathogenic events triggered by HIV-1 in the brain, which ultimately result in neuronal loss and CNS dysfunction (Navia et al., 1986a,b; reviewed in Lipton and Gendelman, 1995) have not been fully resolved. Neurons are rarely infected in vivo (Wiley et al., 1986) and it is unlikely that neuronal loss in HIV-1 dementia is caused by cytopathic infection of these cells. Numerous neuropathological, immunocytochemistry, in situ hybridization, and virus isolation studies indicate that macrophages and microglial cells are the primary host cells for productive HIV-1 infection in the CNS (Brew et al., 1995; Koening et al., 1986; reviewed in Lipton and Gendelman, 1995) . It has been suggested that HIV-1 infection, and subsequent activation of these cells, causes neuroin¯ammatory responses involving production of chemokines, cytokines, nitric oxide, and other factors, some of which were shown to be neurotoxic in vitro (reviewed in Kaul et al., 2001; Lipton and Gendelman, 1995) . Viral products secreted by infected cells, including gp120 and Tat, can also induce neurotoxicity in vitro and in animal models (Kaul et al., 2001; Lipton and Gendelman, 1995) .
Astrocytes also can be infected with HIV-1 in vitro and in vivo, although with lower eciency than T cells and macrophages (Dewhurst et al., 1987; Saito et al., 1994; Tornatore et al., 1991 Tornatore et al., , 1994a reviewed in BrackWerner, 1999) . The limited infection of astrocytes has been attributed to various mechanisms, including intracellular restrictions to virus expression (Gorry et al., 1999; Ludwig et al., 1999; Tornatore et al., 1994b) or, as we have shown recently, inecient virus entry (Bencheikh et al., 1999; Canki et al., 2001) . There is general agreement, however, that HIV-1 can persist in astrocytes for prolonged periods in a low productive, non-cytolytic state, from which it can be induced by physiologic stimuli such as tumor necrosis factor-a (TNF-a) (Shahabuddin et al., 1992; Tornatore et al., 1991) . Surveys of autopsy tissues using in situ PCR and sensitive immunocytochemistry techniques indicate that the frequency of HIV-1 positive astrocytes in selected tissue sections from brains of patients with dementia can achieve 1% (Saito et al., 1994; Takahashi et al., 1996; Tornatore et al., 1994a) . Considering that the number of astrocytes in the brain is between 10 11 to 10 12 cells (Verkhratsky et al., 1998) , these cells clearly constitute a major target for HIV-1 infection in the brain. The consequences of this infection with respect to HAD pathogenesis are unknown, but they may be signi®cant. Persistent, non-cytolytic HIV-1 infection in culture alters gene expression in lymphocytes (Geiss et al., 2000; Shahabuddin et al., 1994) and astrocytes (He et al., 1997; Schneider-Schaulies et al., 1992) , indicating that such infections may aect cell function. Exposure of astrocytes to recombinant HIV-1 envelope glycoprotein gp120 alters cell physiology (Benos et al., 1994a) , including a potential eect on glutamate transport as indicated by increased D-aspartate eux in astrocytes treated with gp120 (Benos et al., 1994b) . Impairment of glutamate transport was also observed after incubation of human astrocytes with TNF-a (Fine et al., 1996) or co-cultivation with T cells infected with human T cell leukemia virus type I (HTLVI) (Szymocha et al., 2000) , and similar defects were found in feline astrocytes after infection with feline immunode®ciency virus (FIV) (Yu et al., 1998) . More recent studies indicate that ligation of the HIV-1 coreceptor on astrocytes, CXCR4 by either stromal cell-derived factor 1 (SDF-1) or gp120 can stimulate a novel signaling pathway that involves Ca 2+ -dependent release of glutamate (Sharma and Vijayaraghavan, 2001) in a process including activation of the CXCR4 receptor, an autocrine/paracrine TNF-a-dependent signaling, and prostaglandin (Bezzi et al., 2001) . These results suggest that HIV-1, gp120, and other neuropathogenic agents can alter speci®c signaling pathways in astrocytes in a way that may impair important physiological functions of these cells in neuronal signal transmission and response to brain injury.
Considering these changes in astrocyte physiology by HIV-1 infection or exposure, we sought to determine whether HIV-1 induces speci®c changes in gene expression in astrocytes. In the present study we have employed a new rapid subtraction hybridization (RaSH) method (Jiang et al., 2000) to globally identify human genes whose expression in astrocytes display temporal alterations following HIV-1 infection. Here we describe 15 AEGs, including 13 known and two novel genes that display elevated expression in early passage human fetal astrocytes as a consequence of HIV-1 infection or treatment with gp120. As predicted based on our cloning strategy, AEGs displaying early temporal kinetics, i.e., 6 or 24 h after induction, and late temporal kinetics, i.e., 3 and 7 days after induction, have been identi®ed. The present application of RaSH to cloning astrocyte-regulated genes provides additional support for this scheme for eciently cloning dierentially expressed genes (Jiang et al., 2000; Kang et al., 2001; Simm et al., 2001) . Moreover, the speci®c AEGs induced in astrocytes by HIV-1 infection may represent signi®cant genes regulating astrocyte physiology potentially contributing to HAD.
Results
Infection of human astrocytes with HIV-1 and cloning of the AEGs using the RaSH approach HIV-1 infection of astrocytes alters gene expression and cell function (He et al., 1997; Kort, 1998) . To de®ne the repertoire of genes modi®ed as a consequence of infection of early passage fetal astrocytes with HIV-1 we have used the recently described ecient and rapid cloning approach RaSH (Jiang et al., 2000; Kang et al., 2001; Simm et al., 2001) . A schematic of this approach as applied to this fetal astrocyte model and HIV-1 infection is shown in Figure 1 . For the current study, human fetal astrocytes were cultured and infected with HIV-1 as previously described (Bencheikh et al., 1999; Canki et al., 2001) and pooled RNAs (6, 12, 24 h, and 3 and 7 days) extracted from uninfected and HIV-1 infected early passage fetal astrocytes cultured in parallel were used in RaSH to identify cellular genes displaying elevated expression (AEGs) as a function of HIV-1 infection. HIV-1 infection of astrocytes was con®rmed by following the levels of HIV-1 p24 core antigen in culture supernatants (Figure 2 ). Consistent with previous results from this and other laboratories (Canki et al., 2001; Tornatore et al., 1991) , HIV-1 production by these cells peaked 3 ± 4 days after infection at about 600 pg p24/ml, and it declined thereafter ( Figure 2 ). The cDNA libraries were prepared by synthesizing double-stranded cDNAs, digesting the cDNAs into small fragments with the restriction enzyme DpnII, ligating the fragments to adapters and amplifying by PCR. The DpnII-based RaSH approach was previously shown to generate fragments on average of 256 bp in size (Jiang et al., 2000) . Subtraction hybridization was then performed by incubating the tester (temporal HIV-1 infected astrocyte library) and driver (temporal uninfected astrocyte library) PCR fragments without further PCR ampli®cation. Selection of subtracted cDNAs was achieved by matching the ends of the cDNA fragments to the ends of the plasmid vectors during ligation and construction of subtracted libraries. Initial screening of a large number of clones representing dierential expression of cellular genes was accomplished by reverse Northern hybridization, followed by Northern blotting to con®rm true dierential expression of genes in infected versus control cells (Huang et al., 1999; Kang et al., 1998) . Previous studies document a high degree of conformity (*89%) between reverse Northern and Northern expression of RaSH-derived ESTs (Jiang et al., 2000; Simm et al., 2001) . Using this approach, 15 distinct AEGs displaying enhanced expression as a function of HIV-1 infection were identi®ed by reverse Northern blotting ( Figure 3 ).
Expression analysis and characterization of AEGs
The dierential expression of the RaSH-derived AEGs was con®rmed by Northern blot analyses (Figures 4 ± 6). RNAs were isolated after 6, 12, 24 h, and 3 and 7 days from uninfected, HIV-1 infected, and HIV-1 glycoprotein (gp120)-treated early passage human fetal astrocytes. gp120 treatment was included in this analysis because gp120 alone (without infection with Figure 1 Schematic representation of the RaSH approach as applied to HIV-1 infected early passage human fetal astrocytes. For this scheme tester (HIV-1 infected, 6, 12, and 24 h, and 3 and 7 days) and driver (control uninfected, 6, 12, 24 h, and 3 and 7 days) early passage human fetal astrocytes libraries were constructed followed by digestion of only the tester library with XhoI. After hybridization, dierentially expressed sequences are cloned into XhoI-digested vectors, resulting in a subtracted cDNA library enriched for AEGs displaying elevated expression in human fetal astrocytes as a function of HIV-1 infection intact HIV-1) induces marked functional and geneexpression changes in human astrocytes (Benos et al., 1994b; He et al., 1997; Schneider-Schaulies et al., 1992) . RNA levels were quantitated by Northern blotting, ®rst by probing with a random-primed [ 32 P]-labeled AEG cDNA, followed by stripping of the blot and reprobing with GAPDH. After autoradiography, relative hybridization intensity was determined by densitometry comparisons of AEG/GAPDH for the various temporal uninfected samples relative to HIV-1 infected or gp120-treated normalized (AEG/GAPDH) RNA samples (see Materials and methods). Compared to their expression in control cells, an *1.5-to *4.5-fold temporal increase in expression of the various AEGs was apparent following HIV-1 infection and an *1.5-to *3.2-fold temporal increase was seen following gp120 treatment (Table 1) .
Sequence analysis of the RaSH-derived ESTs revealed 13 previously identi®ed AEGs and two unknown AEGs, AEG-1 (novel) and AEG-11 (novel), not reported in current databases (Table 1) . RaSH identi®ed AEG-1 (novel) in four independent analyses and AEG-2 (G-binding protein) (Baels et al., 1987) in two independent analyses, whereas the remaining AEGs represented single cloning events. However, since only A B Figure 2 Infection of human fetal astrocytes with HIV-1. Astrocytes were infected with HIV-1 and tested for virus expression as described in Materials and methods
Figure 3
Reverse Northern blot analysis of dierentially expressed sequence tags identi®ed by RaSH. Equal quantities of PCR ampli®ed products from random bacterial clones of RaSHderived libraries were loaded onto 1.2% agarose gels. Samples were electrophoresed for 1 h under 100 V and transferred to nylon membranes. The blots were hybridized with 32 P-labeled putative AEGs cDNAs reverse transcribed RNA samples. Blots were exposed for autoradiography. The lane numbers (1 to 16) indicate the various upregulated ESTs, which were designated AEG-1 to 15. AEG-1 is shown twice in lanes 3 and 4 Figure 4 Con®rmation of dierential expression using Northern blotting analysis of AEG-1 to AEG-5 displaying temporal elevated expression following HIV-1 infection or treatment with gp120. Early passage human fetal astrocytes were untreated (control), infected with HIV-1 at an M.O.I. of 1, or treated with 1 nM gp120 for 6 or 24 hours or 3 or 7 days total RNA was isolated and analysed by Northern blotting. Membranes were probed with the indicated radiolabeled [ 32 P] AEG EST, identi®ed by RaSH, the blots were stripped and probed with a radiolabeled [ 32 P] gapdh cDNA probe. Expression was quantitated by densitometric analysis about 20% of the DpnII RaSH subtracted library was screened, it is estimated that this library may contain 5 75 distinct dierentially expressed AEGs.
In general, the temporal pattern and magnitude of enhanced AEG expression was similar in cells infected with HIV-1 or treated with gp120. However, expression of AEG-2 (G-binding protein), AEG-5 (hGNT-IV-H) (Furukawa et al., 1999) , AEG-7 (human CTL2) (O'Regan et al., 2000) , AEG-8 (acidic ribosomal phosphoprotein) (Rich and Stietz, 1987) and AEG-15 (PGK-1) (Michelson et al., 1983; Tsukada et al., 1991) was elevated in fetal astrocyte cultures more rapidly following HIV-1 infection than gp120 treatment (Figures 4 ± 6 ). AEG-2 (G-binding protein), AEG-5 (hGNT-IV-H) and AEG-7 (human CTL2) expression was elevated by 3 day post-infection with HIV-1, whereas enhanced expression of these genes was not apparent until 7 days after gp120 treatment. In the case of AEG-8 (acidic ribosomal phosphoprotein) and AEG-15 (PGK-1) increased expression was apparent by 24 h following infection with HIV-1 and by 3 days following gp120 treatment. Quantitative dierences in enhancement were also apparent, with HIV-1 causing a greater increase than gp120 in the case of AEG-2 (G-binding protein), AEG-3 (GA17 protein) (Ryo et al., 2000) , AEG-7 (human CTL2), AEG-10 (autotaxin) (Kawagoe et al., 1997; Stracke et al., 1994) and AEG-13 (human non-muscle a-actinin) (Youssou®an et al., 1990) .
AEG-3 (GA17 protein), AEG-11 (novel) and AEG-13 (human non-muscle a-actinin) appear to be early response genes, which are elevated by 6 h after infection with HIV-1 or treatment with gp120 (Figures 4 ± 6). In contrast, AEG-1 (novel), AEG-2 (G-binding protein), AEG-4 (unr/NRU) (Boussadia et al., 1993; Jeers et al., 1990) , AEG-5 (hGnT-IV-H), AEG-7 (human CTL2), AEG-8 (acidic ribosomal phosphoprotein), AEG-9 (calnexin) (Honore et al., 1994; Rubio and Wenthold, 1999; Shi et al., 2001) , AEG-10 (autotaxin) and AEG-14 (Gonos, 1998; Prieto et al., Reverse Northern blotting identi®ed potential up-regulated AEGs. Sequencing indicated that AEG-1 had been cloned four times and AEG-2 had been cloned two times, whereas all of the other AEGs were identi®ed once in the 20% of the subtracted library screened by reverse Northern blotting 1999; Schneider et al., 1988) , represent late response genes that display elevated expression by 3 ± 7 day post-treatment (Figures 4 ± 6). Speci®c AEGs had unique temporal expression patterns. In the case of AEG-6 (®bronectin) (Niquet et al., 1994) , elevated expression was predominantly detected 24 h after exposure to HIV-1 or gp120 (Figure 4 ). In the case of AEG-12 (thymosin b-4) (Gondo et al., 1987) , enhanced activity was observed following HIV-1 and gp120 treatment for 24 h and 7 days, whereas no enhancement was apparent at 6 h or 3 days (Figure 6 ). While most of the AEGs hybridized with a single mRNA species, AEG-11 (novel) and AEG-13 (human non-muscle a-actinin) hybridized with two separate mRNA species, which may re¯ect alternate processing of the same gene.
HIV-1 infection and gp120 treatment of early passage fetal astrocytes enhances fibronectin and a-actinin protein expression
To determine if elevated AEG mRNA correlated with enhanced protein expression, we obtained commercially available antibodies to ®bronectin (AEG-6), calnexin (AEG-9) and human non-muscle a-actinin (AEG-13) and tested expression of these proteins in HIV-1 infected and control astrocytes by Western blotting. The results of analyses of ®bronectin and a-actinin protein expression in two independently derived primary human fetal astrocyte cultures are shown in Figure 7 . Although ®bronectin (AEG-6) levels were elevated in both astrocyte cultures following HIV-1 infection, the kinetics of increase was dierent for the two dierent astrocyte cultures. In the cultures analysed in Figure 7a , enhancement was only apparent after 24 h, which correlated with a similar increase in AEG-6 mRNA in these cells following HIV-1 infection ( Figure 5 ). However, in the astrocyte cultures analysed in Figure 7b , increases in ®bronectin were apparent after 6, 24 h and 3 days. Similarly, a-actinin (AEG-13) levels were elevated after HIV-1 infection only at 6 h in the astrocytes in Figure 7a , whereas an increase at 6 h and a small increase at 24 h were apparent in the astrocytes in Figure 7b . The dierence in the temporal kinetics of expression between these two cultures following HIV-1 infection may re¯ect cellular heterogeneity or the growth status of these astrocyte cultures. However, since the cultures in Figure 7b were not examined for ®bronectin or a-actinin mRNA it is not known if mRNA synthesis displayed similar kinetic changes in these cells following HIV-1 infection. We could not detect calnexin (AEG-13) in astrocytes under any conditions. Thus, for two of the AEG products, Figure 6 Con®rmation of dierential expression using Northern blotting analysis of AEG-11 to AEG-15 displaying temporal elevated expression following HIV-1 infection or treatment with gp120. See Materials and methods and Figure 4 for experimental details Figure 7 Expression of AEG-6 and AEG-13 proteins in HIV-1 infected and control astrocytes as determined by Western blotting. Astrocytes were infected with HIV-1 at M.O.I. of 1 or equal to 1 nM gp120, and treated and untreated cells were cultured and sampled at the designated times for immunoblot analysis as described in Materials and methods. Asterisks indicate a double amount of cell lysate loaded per lane. (a and b) represent studies using two independently derived early passage human fetal astrocyte cultures ®bronectin (AEG-6) and a-actinin (AEG-13), HIV-1 induced elevations in mRNA expression correlate with increases in their respective protein levels.
Discussion
The present studies indicate that primary human astrocytes respond to HIV-1 infection or exposure to HIV-1 gp120 by induction of synthesis of a similar panel of cellular genes. Since HIV-1 infection of astrocytes is limited, persisting for prolonged periods in a low productive and non-cytolytic state (Shahabuddin et al., 1992; Tornatore et al., 1991 Tornatore et al., , 1994a , these results suggest that the parallel eects observed following infection with HIV-1 and gp120 treatment may re¯ect gene changes resulting as a consequence of signaling events mediated by cell surface interactions. The dysregulation in cellular gene expression may be one route through which HIV-1 infected astrocytes contribute to HAD, despite relatively inecient viral expression. Here we describe 15 genes identi®ed by the RaSH approach that display elevated expression in astrocytes as a consequence of infection with HIV-1 or treatment with the HIV-1 glycoprotein, gp120. The AEGs include early-responsive genes with elevated expression within 6 h of treatment, i.e., AEG-3 (GA17 protein), AEG-11 (novel) and AEG-13 (human non-muscle a-actinin), and late-responsive genes that display enhanced expression within day 3 ± 7 of treatment, i.e., AEG-1 (novel), AEG-2 (human Gbinding protein), AEG-4 (unr/NRU), AEG-5 (hGnT-IV-H), AEG-7 (human CTL2), AEG-8 (human acidic ribosomal phosphoprotein), AEG-9 (calnexin), AEG-10 (autotaxin) and AEG-14 (gas-6).
The functions of the AEGs in normal astrocyte physiology and the changes induced following HIV-1 infection or treatment with gp120 are not currently known. It is possible that speci®c AEGs may directly or indirectly mediate biochemical changes in astrocytes following treatment with these agents that impact on their growth and biochemical properties. Alternatively, changes in AEG expression may be symptomatic of and associated with alterations mediated by these agents, rather than direct inducers of biological and biochemical changes in the treated astrocytes. In speci®c instances, it is possible to speculate about the putative roles of certain AEGs in astrocyte physiology based on properties previously attributed to these genes.
G proteins, such as the G-binding protein AEG-2, are receptor-associated signal-transduction molecules that can profoundly aect cell physiology and signaling in the brain and defects in these signaling pathways can result in pathophysiology in the brain (Lee et al., 2001; Manji and Lenox, 2000; Mark and Herlitze, 2000; Sidhu and Niznik, 2000) . The cell surface receptors responsible for HIV-1 binding and entry into astrocytes have not been identi®ed. Astrocytes do not express surface CD4, but 125 I-gp120 binds to these cells in vitro with K d that is similar to that of the gp120-CD4 interaction on T cells (Ma et al., 1994) , suggesting the possibility of signal transduction mediated by binding to astrocytic HIV-1 receptor(s). Interestingly, an orphan G protein-coupled receptor GPR1 was recently found to function as a coreceptor for HIV-1 infection on a glioma cell line U87/CD4 (Shimizu et al., 1999) . In addition, at least a sub-population of astrocytes was shown to express the G-protein-coupled receptor CXCR4 (Gabuzda and Wang, 1999) , and the recent study by Bezzi et al. (2001) indicates that activation of this receptor in astrocytes by SDF-1 or X4-tropic gp120 induces a signaling cascade involving TNF-a, prostaglandin E 2 , and Ca 2+ -dependent glutamate exocytosis (Bezzi et al., 2001) . Thus changes in AEG-2 expression, which occur by day 3 in HIV-1 infected and by day 7 in gp120 treated astrocytes, and remain elevated at day 14 and 21 (data not shown), may mediate some of the events described in the work of Bezzi et al. (2001) , or alternatively, modulate signal transduction pathways eecting the excitatory amino acid transporters in astrocytes, some of which display temporal changes following HIV-1 infection or treatment with gp120 (Benos et al., 1994b; and unpublished data) .
Fibronectin, AEG-6, is upregulated in astrocytes of rats treated with kainic acid, a model of temporal lobe epilepsy, resulting in axon ± terminal degeneration of association-®bers (Niquet et al., 1994) . In this manner, upregulation of ®bronectin expression following HIV-1 infection or treatment with gp120 might contribute to the development of HAD, with its associated changes in neuronal survival (Kaul et al., 2001; Navia et al., 1986a) . Of interest is the temporal kinetics of upregulation of AEG-6 by HIV-1 and gp120, which occurs predominantly at 24 h post-treatment. Similar temporal changes in ®bronectin protein are also evident in HIV-1 infected human fetal astrocytes evaluated by Western blotting (Figure 7 ). At present we do not know which ®bronectin isoform is induced by HIV-1/gp120 in astrocytes, but it is likely to be the extracellular form of the protein rather than the plasma ®bronectin (pFn), which is believed to be produced exclusively by hepatocytes (Schwartzbauer, 1991) . A recent surprising report has shown that pFn supports neuronal survival and reduces brain injury following cerebral ischemia in experimental animals (Sakai et al., 2001) . The HIV-1-induced expression of ®bronectin by astrocytes indicated by our results could thus counteract the proposed neuroprotective activity of pFn. Further studies are necessary to de®ne the signi®cance of this change in relationship to fetal astrocyte physiology.
AEG-7, which is the human CTL-2 gene, is a member of a family of genes that may function as suppressors of choline transport (O'Regan et al., 2000) . The CTL-1 gene was cloned by functional complementation in yeast using a Torpedo electric lobe yeast expression library (O'Regan et al., 2000) . When overexpressed in yeast, high-anity choline uptake increased. Choline transport is essential in cholinergic neurons where it participates in the synthesis of the neurotransmitter acetylcholine. In this context, it is possible that production of this gene product in astrocytes could interfere with choline availability, thereby indirectly altering neuronal function. In addition, according to a recent report, astrocytes themselves express functional alpha-bungarotoxin acetylcholine receptors (a-Bgt-AchRs) (Sharma and Vijayaraghavan, 2001 ) and their activation by synaptically released acetylcholine may play a role in the proposed astrocytic modulation of synaptic transmission (Iino et al., 2001; Oliet et al., 2001; Sharma and Vijayaraghavan, 2001 ). Thus, impairment of choline transport in astrocytes could directly aect astrocyte functions associated with the proposed glianeuron communication, as well as impact signal transmission by cholinergic neurons.
AEG-9, calnexin, is a molecular chaperone that interacts with alpha-amino-3-hydoxy-5-methyl-4-isoxazolepropionate (AMPA) receptors isolated from the rat forebrain (Honore et al., 1994; Rubio and Wenthold, 1999) . The AMPA type glutamate receptors (AMPARs) mediate most of the excitatory synaptic transmission in the brain (Shi et al., 2001) . Recent studies show that astrocytes express a variety of neurotransmitter receptors, including non-NMDA ionotropic glutamate receptors and AMPA/kainite receptors (Porter and McCarthy, 1997) . Such receptors have been detected on hippocampal astrocytes, Bergmann glia, and retinal astrocytes and their stimulation with kainite or AMPA induced both depolarization of astrocytes and Ca 2+ in¯ux (Porter and McCarthy, 1997) . Recently, Iino et al. (2001) showed that AMPA-R mediated Ca 2+ in¯ux in Bergmann glia plays an important role in maintaining structural and functional integrity of glutamergic synapses in the cerebellum. In this context, the upregulation of AEG-9 at days 3 and 7 following HIV-1 infection or treatment with gp120 may alter the functionality of the AMPA receptors and thereby impact on astrocyte-neuronal interactions. It is of interest regarding AEG-7 and AEG-9 that both the aBgt-AchRs and AMPARs are present and functional in hippocampal astrocytes (Porter and McCarthy, 1997; Sharma and Vijayaraghavan, 2001) . HIV-1 infection shows predilection to certain regions of the brain and deep gray matter structures, especially the basal ganglia, were found to contain high virus burden in patients with HIV-1 encephalopathy (Achim et al., 1994) . This may indicate that astrocytes in this region of the brain could be more vulnerable to the potential AEG-7 and AEG-9-regulatory eects of HIV-1 or gp120.
AEG-14 (gas-6) is a ligand for members of the Axl subfamily of protein ± tyrosine kinases, and one of these receptors, Tyro-3, is widely expressed in the central nervous system (Prieto et al., 1999) . Gas-6 expression is enhanced during growth arrest as well as during senescence (Gonos, 1998; Schneider et al., 1988) . The late expression of AEG-14 (gas-6), apparent by day 3 with maximum expression at day 7, may re¯ect the induction of growth suppression in astrocytes infected with HIV-1 or treated with gp120, apparent after weeks in culture. It has been shown that HIV-1 induces astrocyte apoptosis in vitro (He et al., 1997; Shi et al., 1996) and in HIV-1 infected patients (Shi et al., 1996) . Interestingly, the astrocyte apoptotic process in vitro was slow, and it was clearly detected only 20 ± 30 days after HIV-1 infection (Shi et al., 1996) , perhaps consistent with the late upregulation of AEG-14 by HIV-1 or gp120 observed here ( Figure  6 ).
Potential roles for the remaining AEGs in regulating astrocyte physiology following HIV-1 infection or treatment with gp120 remain more speculative. Planned studies of cell-and tissue-speci®c expression of the AEGs in vitro, experiments to block or enhance their expression in astrocytes, and testing their expression in brain autopsy samples from healthy and HIV-1 infected individuals will help us to identify the AEGs that may play critical roles in HIV-1 induced astrocyte dysfunction.
In summary, we have used the RaSH approach as an ecient and rapid means of identifying astrocyte genes that display elevated expression after exposure of astrocytes to gp120 or infection with HIV-1 in vitro. Fifteen AEGs have been uncovered in the present study, providing potential clues for understanding HIV-1 eects on human fetal astrocytes. Further experiments are necessary to determine if the presently identi®ed AEGs are causally related or simply associated with changes induced in astrocyte properties, such as inhibition of glutamate transport, following infection with HIV-1. Although a daunting challenge, these studies are worthwhile and may provide important insights into the process of HIV-1-associated dementia (HAD).
Materials and methods

Human fetal astrocytes, other cells and cell culture conditions
Fetal astrocytes were isolated from second trimester (gestational age 16 ± 19 weeks) human fetal brains obtained from elective abortions in full compliance with NIH guidelines, as previously described (Bencheikh et al., 1999; Canki et al., 2001) . Highly homogenous preparations of astrocytes were obtained using high-density culture conditions in the absence of growth factors in F12 Dulbecco's Modi®ed Eagle Medium (GIBCO-BRL, Gaithersburg, MD, USA) containing 10% fetal bovine serum (FBS), penicillin, streptomycin, and gentamycin. Cells were maintained in this medium at 2 ± 5610 4 cells/cm 2 and subcultured weekly up to six times. For each experiment a single batch of astrocytes of similar gestational age and passage was used. Cultures were regularly monitored for expression of the astrocytic marker glial ®brillary acidic protein (GFAP) and either HAM56 or CD68 to identify cells of monocyte/macrophage lineage. Only cultures that contained 599% GFAP positive astrocytes and rare or no detectable HAM56 or CD68 positive cells were used in these experiments (Canki et al., 2001) . Other cells used in this study were the human embryonal-kidney epithelial cell line 293T (Graham et al., 1977) , used for HIV-1 propagation and MAGI cells, a derivative of HeLa carrying the b-gal gene under the control of HIV-1 LTR and expressing HIV-1 receptors (Kimpton and Emerman, 1992) , used as indicator cells for HIV-1 titration. Both cell lines were cultured in 90% DMEM/10% FBS supplemented with antibiotics and, for MAGI cells, 0.2 mg/ml G-418. Culture media and cells were tested for mycoplasma contamination using the Mycoplasma PCR ELISA kit (Roche Molecular Biochemicals, Indianapolis, IN, USA) and found to be negative.
HIV-1 propagation
The HIV-1 strain used in this work was NL4-3, a prototypical X4-tropic laboratory clone of HIV-1 that expresses all known HIV-1 proteins (Adachi et al., 1986) . Virus propagation was initiated by transfection of 15 mg of NL4-3 DNA into 1.5610 6 293T cells as previously described (Bencheikh et al., 1999) . Culture supernatants were harvested 72 h after transfection, ®ltered through a 0.45 mm Millipore ®lters, and stored at 7808C until use. Cell-free viral stock was tested for HIV-1 p24 core antigen content by ELISA using HIV-1 Ag kit according to the manufacturer's instructions (Coulter, Hialeah, FL, USA), and for titers of infectious virus by multinuclear activation of a b-galactosidase indicator (MAGI) assay (Kimpton and Emerman, 1992) . Culture supernatants contained 1 ± 2 mg/ml of viral p24 protein and 1 ± 2610 6 infectious units (I.U.) per ml. In our experience, a multiplicity of infection (M.O.I.) of one for CD4-positive T cells is approximately 1 pg viral p24 per cell (Canki et al., 2001; Dewhurst et al., 1987) . Virus stocks were also tested for mycoplasma contamination as described above and for endotoxin using the E-TOXATE kit (Limulus Amebocyte Lysate, Sigma, St. Louis, MO, USA), and found to be negative in both tests.
HIV-1 infection of astrocytes with HIV-1 or exposure of the cells to gp120, and preparation of samples for cellular RNA analysis Con¯uent cultures of human fetal astrocytes in 225 cm 2 culturē asks were exposed to HIV-1 in 10 ml of medium at 1 pg p24 per cell for 2 h at 378C, washed three times in warm PBS, and cultured in astrocyte culture medium as described. Control astrocytes were treated as described above but without HIV-1. At 6, 12, 24 h, 3 and 7 days after infection, culture supernatants were removed, and control and infected cells were washed three times in PBS and solubilized by addition of 10 ml of 4M guanidine isothiocyanate directly to culture¯asks. Cell lysates were stored at 7808C until further use. To insure preparation of sucient amount of RNA for subsequent subtractive hybridization, astrocyte cultures and HIV-1 infections were scaled up to approximately 1610 8 cells per time point (infected or control cells); the RNA yield was 5 ± 10 mg per 10 6 cells. Infection of astrocytes with HIV-1 was veri®ed by testing the levels of HIV-1 p24 antigen in culture supernatants by p24 ELISA as described previously (Bencheikh et al., 1999; Canki et al., 2001) . gp120 used for these experiments was a full-length, glycosylated protein from HIV-1 MN produced from baculovirus vector and puri®ed by ImmunoDiagnostics, and provided through the AIDS Research and Reference Reagent Program (Rockville, MD, USA). For gp120 treatment of astrocytes, large-scale cultures of cells prepared as described above were treated with gp120 at 1 nM in 10 ml medium for 2 h, and cells were washed, cultured, and extracted for RNA isolation as described for HIV-1 infection.
RNA isolation and Northern blot analysis
Uninfected, HIV-1 infected and exposed gp120 astrocytes were treated with 4M-guanidinium and total RNA was isolated by the guanidinium/phenol procedure and analysed by Northern blotting as described previously (Jiang and Fisher, 1993; Kang et al., 1998 Kang et al., , 2001 . Northern blots were quantitated by densitometric analysis using a Molecular Dynamics densitometer (Sunnyvale, CA, USA). Relative expression of the dierent AEGs versus GAPDH expression was determined at dierent time points for HIV-1 infected (H-AEG/H-GAPDH), gp120-treated (G-AEG/G-GAPDH) and control uninfected cultures (C-AEG/C-GAPDH). Relative fold-increase in expression of each AEG at 6, 12, 24 h, 3 and 7 days was then determined for each condition by dividing H-AEG/H-GAPDH by C-AEG/C-GAPDH=fold HIV upregulation; or by dividing G-AEG/G-GAPDH by C-AEG/C-GAPDH=fold gp120 upregulation. Poly(A) RNA was puri®ed using Oligo(dT) cellulose columns (GIBCO BRL).
AEGs protein analysis by immunoblotting
Analysis of AEGs protein products in astrocytes was determined by immunoblotting. Astrocytes were infected with HIV-1 at an M.O.I. of 1, washed, and cultured in parallel with uninfected controls as described above. At the designated times, cells were counted and lysed in a buer containing 1% Triton X-100, 0.1% SDS, 1% sodium deoxycholate, 5 mM iodoacetamide, 0.2 U/ml phenylmethylsulfonyl¯uoride; cell lysates corresponding to equivalent number of cells were resolved by SDS ± PAGE on 4 ± 15% polyacrylamide ready gels (Bio-Rad, Hercules, CA, USA) and transferred onto a 0.2 mm Trans-Blot nitrocellulose membrane (Bio-Rad). The membranes were incubated in 5% (w/v) skim milk in T-PBS (0.1% polyoxyethyline ± sorbitan monolaurate in phosphate buered saline) and then stained with the indicated primary antibodies followed by horseradish peroxidase-conjugated second antibody. Protein bands were visualized on an X-ray ®lm after luminescence reaction using an ECL kit (Amersham, Arlington, IL, USA). Samples were standardized by their atubulin content prior to ®nal evaluations. Antibodies used were: rabbit polyclonal anti-®bronectin antibody (Abcam, Cambridge, UK), monoclonal anti-a-actinin (Sigma), and monoclonal anti-a-tubulin (Sigma).
RaSH procedure
Primer design The sequences of oligonucleotides that were used are as follows: XDPN-18 CTGATCACTCGAGA-GATC, XDPN-14 CTGATCACTCGAGA, XDPN-12 GATCTCTCGAGT. The adapters formed from the two sets of oligonucleotides contained an XhoI recognition site.
Preparation of PCR-based cDNA libraries To clone cDNAs expressed at elevated levels in early passage human fetal astrocytes, 1 mg of poly(A) RNA from temporally spaced (6, 12, 24 h, and 3 and 7 days) uninfected astrocytes (driver) or temporally spaced (6 12, 24 h, and 3 and 7 days) HIV-1 infected astrocytes (tester) prepared as described above was used for double-stranded cDNA synthesis using standard protocols (Gubler and Homan, 1983) . The cDNAs were digested with DpnII (New England Biolab, Beverly, MA, USA) at 378C for 3 h followed by phenol/chloroform extraction and ethanol precipitation. The digested cDNAs were mixed with primers XDPN-14/XDPN-12 (®nal concentration 20 mM) in 30 ml of 1X ligation buer (GIBCO BRL), heated at 558C for 1 min, and cooled down to 148C within 1 h. After adding 3 ml of T4 ligase (5 U/ml) (GIBCO BRL) to the mixtures individually, ligation was carried out at 148C overnight. The mixtures were diluted to 100 ml with TE buer (pH 7.0), and at least 40 ml of the mixtures were used for PCR ampli®cation. The PCR mixtures were set up as follows: 1 ml of the cDNA mixture, 10 ml 10X PCR buer, 1 mM MgCl 2 , 0.4 mM dNTPs, 1 mM XDPN-18, and 1 U Taq polymerase (GIBCO BRL). The parameters for PCR were one cycle for 5 min at 728C followed by 25 cycles for 1 min at 948C, 1 min at 558C, 1 min at 728C preceded by one cycle for 3 min at 728C. The PCR products were pooled and puri®ed using Centricon columns (Amicon, Bedford, MA, USA). Ten mg of the tester PCR products were digested with XhoI followed by phenol/chloroform extraction and ethanol precipitation.
Subtraction hybridization and generation of subtracted libraries
One hundred ng of the tester cDNA were mixed with 3 mg of the driver cDNA in 10 ml of a hybridization solution (0.5 M NaCl, 50 mM Tris pH 7.5, 0.2% SDS, 40% formamide), and after boiling for 5 min, incubated at 428C for 48 h. The hybridization mixture was phenol/chloroform extracted, ethanol precipitated, and dissolved in 20 ml of TE buer. One ml of the mixture was ligated with 1 mg of XhoI-digested, CIP-treated pCRII plasmids, overnight at 148C, and transformed into Shot-1 bacteria.
Colony screening
Bacterial colonies were randomly picked and PCR ampli®ed. The PCR products were blotted onto ®lters and reverse Northern blotting was performed to identify cDNAs displaying dierential expression in HIV-1 infected versus uninfected early passage human fetal astrocytes (Huang et al., 1999; Jiang et al., 2000; Kang et al., 1998) . cDNAs displaying elevated expression in HIV-1 infected fetal astrocytes versus uninfected fetal astrocytes were designated AEG with a clone number of 1 to 15. Appropriate expression of the AEG clones identi®ed by reverse Northern blotting was con®rmed by Northern blotting. The sequences of these clones were determined using automated cycle sequencing at the DNA facility of Columbia University.
